2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pelvic Neoplasms
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Mesothelioma
1
Malignant Solid Neoplasm
1
Lung Neoplasms
1
Leiomyoma
1
Colorectal Neoplasms
1
Colonic Polyps
1
Colonic Neoplasms
1
Chylous Ascites
1
Carcinoma, Non-Small-Cell Lung
1
Adenomyosis
1
Abdominal Neoplasms
1
Interventions
Colonoscopy
20
Endoscopic Mucosal Resection
6
Polyethylene Glycols
4
Diagnosis, Computer-Assisted
3
Surgical Instruments
2
Narrow Band Imaging
2
MoviPrep
2
sodium phosphate
1
prucalopride
1
picosulfate sodium
1
peppermint oil
1
maltodextrin
1
Surveys and Questionnaires
1
Sulindac
1
Simethicone
1
Ringer's Lactate
1
Reference Standards
1
Proflavine
1
Optical Imaging
1
Occult Blood
1
Myotomy
1
Menthol
1
Mass Screening
1
Laparoscopy
1
Iohexol
1
Hydroxyethyl Starch Derivatives
1
Folic Acid
1
Endoscopy
1
Eflornithine
1
Diatrizoate Meglumine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Polyps
×
Iohexol
×
Clear all
NCT01200303
2015-08-05
ncCTC
Massachusetts General Hospital
Phase 2/3
Completed
605 enrolled